Chicago, IL — The Hippocratic Cancer Research Foundation (HCRF) will welcome supporters, medical leaders, philanthropists, and families from around the world this weekend for the 11th Annual Wings to Cure Gala, a premier fundraising event dedicated to advancing groundbreaking cancer research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
As one of the nation’s most impactful philanthropic organizations supporting innovative cancer research, HCRF continues to drive scientific discovery, patient care, and global cancer awareness. The Foundation’s mission is to fund high-impact research, accelerate lifesaving treatments, and transform the future of cancer care.
Eleni Bousis: A Global Leader in Cancer Philanthropy
The extraordinary success and global reach of HCRF is rooted in the unwavering leadership of Eleni Bousis, Founder and Chairwoman of the Hippocratic Cancer Research Foundation. A nationally recognized philanthropist, community leader, and advocate for patient support, Bousis has dedicated her life to advancing cancer innovation and standing with families touched by the disease.
Her vision has helped propel HCRF into an international force—funding cutting-edge immunotherapy, cellular engineering, clinical trials, and next-generation cancer treatments. Under her leadership, HCRF has mobilized millions of dollars toward research that is saving lives, improving outcomes, and giving hope to patients once left without options.
A Gala With Purpose: Fueling Breakthrough Cancer Research
Cancer remains one of the world’s most urgent health challenges, claiming nearly 10 million lives annually. HCRF is committed to changing that reality through strategic investment in pioneering research, including:
- Next-generation immunotherapies
- Precision oncology advancements
- High-impact clinical trials
- Innovations in survivorship and cancer wellness
- Breakthrough cellular engineering projects
Funds raised at the Wings to Cure Gala will directly support these transformational programs—advancing science from the laboratory to the bedside.
What Guests Can Expect at the 2025 Wings to Cure Gala
The 11th Annual Wings to Cure Gala promises an unforgettable evening of inspiration and impact, featuring:
- A high-energy live auction with exclusive one-of-a-kind experiences
- Powerful addresses from world-renowned cancer researchers
- Survivor stories that highlight the real-world impact of HCRF’s mission
- A luxury culinary experience led by Executive Chef Nikolaos Kapernaros
- Live entertainment curated to celebrate hope, resilience, and healing
The gala is more than an event—it is a global movement, bringing together leaders from medicine, business, science, philanthropy, and the Greek-American community to fight cancer through innovation and unity.
Strengthening the Future of Cancer Care
HCRF’s investment strategy for 2025 includes notable research allocations such as:
- $400,000 for advanced cancer bioengineering
- $600,000 for next-generation immunotherapy
- Over $1,000,000 toward clinical research and patient trials
These investments reinforce the Foundation’s commitment to accelerating discovery, empowering patients, and leading the global fight against cancer.
A Message of Hope
As HCRF reminds supporters every year:
Every breakthrough begins with support like yours. Together, we can conquer cancer.
For more information about the Hippocratic Cancer Research Foundation, the Wings to Cure Gala, or ways to support cancer research, please visit www.hcrfwingstocure.org.
Please wait...